JP2014533518A5 - - Google Patents

Download PDF

Info

Publication number
JP2014533518A5
JP2014533518A5 JP2014542951A JP2014542951A JP2014533518A5 JP 2014533518 A5 JP2014533518 A5 JP 2014533518A5 JP 2014542951 A JP2014542951 A JP 2014542951A JP 2014542951 A JP2014542951 A JP 2014542951A JP 2014533518 A5 JP2014533518 A5 JP 2014533518A5
Authority
JP
Japan
Prior art keywords
polypeptide
ugt
seq
amino acid
set forth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014542951A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014533518A (ja
JP6084983B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/002857 external-priority patent/WO2013076577A1/en
Publication of JP2014533518A publication Critical patent/JP2014533518A/ja
Publication of JP2014533518A5 publication Critical patent/JP2014533518A5/ja
Application granted granted Critical
Publication of JP6084983B2 publication Critical patent/JP6084983B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014542951A 2011-11-23 2012-11-19 モグロシド化合物の酵素的合成のための方法および材料 Active JP6084983B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161563303P 2011-11-23 2011-11-23
US61/563,303 2011-11-23
PCT/IB2012/002857 WO2013076577A1 (en) 2011-11-23 2012-11-19 Methods and materials for enzymatic synthesis of mogroside compounds

Publications (3)

Publication Number Publication Date
JP2014533518A JP2014533518A (ja) 2014-12-15
JP2014533518A5 true JP2014533518A5 (enExample) 2016-09-29
JP6084983B2 JP6084983B2 (ja) 2017-02-22

Family

ID=47624376

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014542951A Active JP6084983B2 (ja) 2011-11-23 2012-11-19 モグロシド化合物の酵素的合成のための方法および材料

Country Status (14)

Country Link
US (2) US9920349B2 (enExample)
EP (1) EP2783009B1 (enExample)
JP (1) JP6084983B2 (enExample)
KR (1) KR101791597B1 (enExample)
CN (1) CN103958693B (enExample)
AU (2) AU2012342114B2 (enExample)
BR (1) BR112014012543A2 (enExample)
CA (1) CA2853677C (enExample)
IN (1) IN2014CN03557A (enExample)
MX (1) MX342851B (enExample)
MY (1) MY170686A (enExample)
RU (1) RU2633644C2 (enExample)
SG (1) SG11201401927PA (enExample)
WO (1) WO2013076577A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3176307A1 (en) 2010-06-02 2011-12-08 Evolva Nutrition, Inc. Recombinant production of steviol glycosides
EP2742142B2 (en) 2011-08-08 2020-03-25 Evolva SA Recombinant production of steviol glycosides
SG11201401927PA (en) 2011-11-23 2014-09-26 Evolva Sa Methods and materials for enzymatic synthesis of mogroside compounds
TW201402599A (zh) * 2012-05-30 2014-01-16 Suntory Holdings Ltd 甜菊糖苷糖苷轉化酵素及編碼該酵素之基因
MX367859B (es) 2012-12-04 2019-09-09 Evolva Sa Metodos y materiales para la biosintesis de compuestos mogrosidos.
KR20150128705A (ko) 2013-02-11 2015-11-18 에볼바 에스아 재조합 숙주에서 스테비올 글리코시드의 효율적인 생성
WO2016023844A1 (en) 2014-08-11 2016-02-18 Evolva Sa Production of steviol glycosides in recombinant hosts
CA2960693A1 (en) 2014-09-09 2016-03-17 Evolva Sa Production of steviol glycosides in recombinant hosts
CA2972739A1 (en) 2014-09-11 2016-03-17 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Methods of producing mogrosides and compositions comprising same and uses thereof
JP2017529860A (ja) 2014-10-01 2017-10-12 エヴォルヴァ エスアー.Evolva Sa. モグロシド化合物の生合成のための方法および材料
JP6698028B2 (ja) * 2014-10-17 2020-05-27 サントリーホールディングス株式会社 モグロール配糖体化酵素およびそれをコードする遺伝子
CA2974185A1 (en) 2015-01-20 2016-07-28 Suntory Holdings Limited Method for preparing mogroside
CA2973674A1 (en) 2015-01-30 2016-08-04 Evolva Sa Production of steviol glycosides in recombinant hosts
CN115851470B (zh) 2015-03-16 2025-09-02 帝斯曼知识产权资产管理有限公司 Udp-糖基转移酶
EP3332018B1 (en) 2015-08-07 2022-07-27 Evolva SA Production of steviol glycosides in recombinant hosts
MX395362B (es) 2015-10-29 2025-03-11 Firmenich Incorporated Edulcorantes de alta intensidad
CN106924274B (zh) * 2015-12-29 2019-01-04 成都普睿法药物研发有限公司 葫芦烷型四环三萜类化合物抗肺纤维化应用
MY198001A (en) 2016-04-13 2023-07-25 Evolva SA Production of steviol glycoside in recombinant hosts
JP2019519212A (ja) * 2016-05-16 2019-07-11 エヴォルヴァ エスアー.Evolva Sa. 組換え宿主内でのステビオールグリコシドの産生
US10815514B2 (en) 2016-05-16 2020-10-27 Evolva Sa Production of steviol glycosides in recombinant hosts
JP6845244B2 (ja) * 2016-07-19 2021-03-17 サントリーホールディングス株式会社 モグロールまたはモグロール配糖体の生産方法
EP3535406A1 (en) 2016-11-07 2019-09-11 Evolva SA Production of steviol glycosides in recombinant hosts
EP3615679A4 (en) 2017-05-03 2021-02-17 Firmenich Incorporated PROCESS FOR THE MANUFACTURING OF HIGHLY INTENSE SWEETENERS
US11653680B2 (en) 2017-05-19 2023-05-23 The Coca-Cola Company Siamenoside I sweetened compositions and uses of the same
CN110719738B (zh) 2017-06-02 2023-06-09 奇华顿股份有限公司 组合物
WO2021214008A1 (en) 2020-04-20 2021-10-28 Givaudan Sa Compositions
US11248248B2 (en) 2017-06-15 2022-02-15 Evolva Sa Production of mogroside compounds in recombinant hosts
CN107189976B (zh) * 2017-07-28 2022-03-11 李华政 促进罗汉果ugt72b21基因表达的方法
KR20210090218A (ko) 2018-11-07 2021-07-19 피르메니히 인코포레이티드 고강도 감미료의 제조 방법
CN113286523A (zh) 2018-11-07 2021-08-20 弗门尼舍公司 制备高强度甜味剂的方法
CA3118924A1 (en) 2018-11-09 2020-05-14 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides
CN110669094B (zh) * 2019-10-14 2021-12-21 上海交通大学 罗汉果新苷及其制备方法
KR102362135B1 (ko) * 2019-10-25 2022-02-14 고려대학교 산학협력단 테르펜 당쇄 부가 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 조성물
MX2022011627A (es) * 2020-03-17 2022-12-15 Coca Cola Co Nuevo sistema y métodos de producción de mogrósidos.
GB202007984D0 (en) 2020-05-28 2020-07-15 Givaudan Sa Compositions
CN112063647B (zh) * 2020-09-17 2023-05-02 云南农业大学 酿酒酵母重组菌Cuol01的构建方法、酿酒酵母重组菌Cuol02及应用
CN116064712B (zh) * 2022-10-08 2025-05-06 中国药科大学 一种罗汉果醇的生物合成方法
WO2024218244A1 (en) 2023-04-20 2024-10-24 Dsm Ip Assets B.V. Strains and methods for the production of mogrosides

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399321B1 (en) * 1999-08-18 2002-06-04 National Research Council Of Canada Methods for screening UDP-glucose:glycoprotein glucosyltransferase (UGGT) activity and nucleic acid encoding for UGGT
EP1510573A1 (en) * 2003-09-01 2005-03-02 Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung Method for detoxification of mycotoxins
US20080148432A1 (en) * 2005-12-21 2008-06-19 Mark Scott Abad Transgenic plants with enhanced agronomic traits
WO2006092449A2 (en) 2005-03-02 2006-09-08 Metanomics Gmbh Process for the production of fine chemicals
US8257948B1 (en) * 2011-02-17 2012-09-04 Purecircle Usa Method of preparing alpha-glucosyl Stevia composition
US8956677B2 (en) 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with glucosamine and compositions sweetened therewith
RU2008122901A (ru) 2005-11-23 2009-12-27 Дзе Кока-Кола Компани (US) Композиция интенсивного подсластителя с сапонином и подслащенные ею композиции
US7927851B2 (en) 2006-03-21 2011-04-19 Vineland Research And Innovation Centre Compositions having ent-kaurenoic acid 13-hydroxylase activity and methods for producing same
WO2008062165A2 (en) * 2006-11-22 2008-05-29 The University Of York Monoterpenoid modifying enzymes
US20100132073A1 (en) * 2006-12-01 2010-05-27 The University Of York Sesquiterpenoid modifying enzymes
GB0904639D0 (en) * 2009-03-18 2009-04-29 Univ York Assay
CA3176307A1 (en) 2010-06-02 2011-12-08 Evolva Nutrition, Inc. Recombinant production of steviol glycosides
SG11201401927PA (en) 2011-11-23 2014-09-26 Evolva Sa Methods and materials for enzymatic synthesis of mogroside compounds
MX367859B (es) 2012-12-04 2019-09-09 Evolva Sa Metodos y materiales para la biosintesis de compuestos mogrosidos.

Similar Documents

Publication Publication Date Title
JP2014533518A5 (enExample)
Schoeman et al. Coronavirus envelope protein: current knowledge
JP2023179436A5 (enExample)
Tsai et al. Baculovirus as versatile vectors for protein display and biotechnological applications
JP2018520997A5 (enExample)
JP2012095652A5 (enExample)
JP2009523422A5 (enExample)
Maeda et al. The intracellular association of the nucleocapsid protein (NP) of hantaan virus (HTNV) with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9)
EP2385107A8 (en) Lentiviral vector based immunological compounds against malaria
JP2008524261A5 (enExample)
RU2015152086A (ru) Пептиды, подавляющие инфекции респираторных вирусов, их применение и способы получения
Florian et al. Characterization of the anti‐HBV activity of HLP1–23, a human lactoferrin‐derived peptide
Berglund et al. Viral alteration of cellular translational machinery increases defective ribosomal products
Molouki et al. The matrix (M) protein of Newcastle disease virus binds to human bax through its BH3 domain
Li et al. Identification and characterization of a prawn white spot syndrome virus gene that encodes an envelope protein VP31
RU2015148190A (ru) Слитые полипептиды и вакцины
CN102311500B (zh) 一种抗病毒融合蛋白及其应用
AU2016313660B2 (en) Polypeptide carrier for presenting target polypeptide and uses thereof
CN114736293B (zh) SARS-CoV-2中和性纳米抗体、自组装铁蛋白融合纳米抗体及制备方法和应用
JP2010279373A5 (enExample)
Zhu et al. Transcription and identification of a novel envelope protein (VP124) gene of shrimp white spot syndrome virus
Jie et al. The C-terminal region of envelope protein VP38 from white spot syndrome virus is indispensable for interaction with VP24
Chen et al. Characterization of a novel envelope protein WSV010 of shrimp white spot syndrome virus and its interaction with a major viral structural protein VP24
CN104628849A (zh) 单克隆抗体mers-4及其编码基因和应用
US20230302083A1 (en) Highly-networked coronavirus immunogen composition